Bayer, J&J Misrepresented Xarelto Risks, Suits Say
Bayer HealthCare Pharmaceuticals Inc. and Johnson & Johnson unit Janssen Pharmaceuticals Inc. have downplayed the risks associated with their blood thinner Xarelto, two couples allege in separate suits filed in New...To view the full article, register now.
Already a subscriber? Click here to view full article